Simon Dazhong Lu
Director/Board Member bei ASCENTAGE PHARMA GROUP INTERNATIONAL
Vermögen: - $ am 31.03.2024
Profil
Simon Dazhong Lu is a Non-Executive Director at Ascentage Pharma Group International Co., Ltd.
He was previously a Director at McGill University, Managing Director at CEL Partners Co. Ltd., and Partner & Investment Manager at Shanghai NewMargin Ventures Investment Management Co. Ltd.
He also worked as an Auditor at Arthur Andersen Business Consulting Co. Ltd.
(Shanghai).
Lu holds a doctorate degree from Nankai University, which he received in 2010, and an undergraduate degree from the same university, which he received in 1991.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Simon Dazhong Lu
| Unternehmen | Position | Beginn |
|---|---|---|
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Director/Board Member | 06.07.2018 |
Ehemalige bekannte Positionen von Simon Dazhong Lu
| Unternehmen | Position | Ende |
|---|---|---|
| McGill University | Director/Board Member | 01.11.2018 |
CEL Partners Co. Ltd.
 CEL Partners Co. Ltd. Investment ManagersFinance CEL Partners is an independent China-based private equity firm which was established in 2007 to manage China Equity Links SAS, the first independent continental Europe private equity fund dedicated to investments in China. Based in Beijing, CEL Partners is comprised of Chinese and Western professionals, complemented by a team of Senior Advisors. The China Equity Links fund is backed by global financial institutions including Crédit Agricole, Société Générale, Caisse des Dépôt et des Consignations, Savings Bank Group, CNP, Groupama and Scor and has an office in Paris, France. | Chief Executive Officer | 01.07.2009 |
Shanghai NewMargin Ventures Investment Management Co. Ltd.
 Shanghai NewMargin Ventures Investment Management Co. Ltd. Investment ManagersFinance Shanghai NewMargin Ventures Investment Management Co. Ltd. is an Independent Venture Capital firm founded in 1999 by Tao Feng. Shanghai NewMargin Ventures Investment Management Co. Ltd. is headquartered in Shanghai. | Chief Investment Officer | 01.12.2007 |
| Arthur Andersen Business Consulting Co. Ltd. (Shanghai) | Comptroller/Controller/Auditor | - |
Ausbildung von Simon Dazhong Lu
| Nankai University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Shanghai NewMargin Ventures Investment Management Co. Ltd.
Shanghai NewMargin Ventures Investment Management Co. Ltd. Investment ManagersFinance Shanghai NewMargin Ventures Investment Management Co. Ltd. is an Independent Venture Capital firm founded in 1999 by Tao Feng. Shanghai NewMargin Ventures Investment Management Co. Ltd. is headquartered in Shanghai. | Finance |
CEL Partners Co. Ltd.
CEL Partners Co. Ltd. Investment ManagersFinance CEL Partners is an independent China-based private equity firm which was established in 2007 to manage China Equity Links SAS, the first independent continental Europe private equity fund dedicated to investments in China. Based in Beijing, CEL Partners is comprised of Chinese and Western professionals, complemented by a team of Senior Advisors. The China Equity Links fund is backed by global financial institutions including Crédit Agricole, Société Générale, Caisse des Dépôt et des Consignations, Savings Bank Group, CNP, Groupama and Scor and has an office in Paris, France. | Finance |
| Arthur Andersen Business Consulting Co. Ltd. (Shanghai) |
